编辑丨于靖
2022年第一季度是三年来新股发行最慢的一个季度,迫使初创的制药企业在更艰难的融资环境中另寻出路。
想要上市的生物科技公司正面临着一个与一年前完全不同的世界。
行业股价暴跌,过去两年创下纪录的IPO步伐也因此放缓。初创的制药企业再也无法获得2021年...查看全文
chuminhua2022-03-28 16:26
3月25日,AN2 Therapeutics 扩大 IPO 规模,募集 6900 万美元用于从辉瑞(Pfizer)的 Anacor Pharmaceuticals 获得的抗生素epetraborole的关键试验。
epetraborole 是一种细菌亮氨酰-tRNA 合成酶的小分子抑制剂,Anacor 和葛兰素史克在十多年前进行了临床试验。葛兰素史克在 2 期试验中发现一...查看全文
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005545 Size: 5 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005550 Size: 5 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021812 Act: 34 Size: 77 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-23-000525 Act: 34 Size: 277 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-020803 Act: 34 Size: 140 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000078003-23-000011 Act: 34 Size: 75 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-019766 Act: 34 Size: 35 KB 网页链接
$AN2 Therapeutics(ANTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-032801 Act: 34 Size: 92 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-035782 Size: 10 KB 网页链接
$AN2 Therapeutics(ANTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-035472 Size: 11 KB 网页链接